×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1739 Total Publications

Epistatic genetic effects among Alzheimer's candidate genes
Hohman, T. J., Koran, M. E., & Thornton-Wells, T.
PMID: 24260488 ; PMCID:3832488 ; 2013; Journal PloS One; vol. 8; no. 11; pp. 1-7; doi:10.1371/journal.pone.0080839
Generating a Minimal Set of Templates for the Hippocampal Region in MR Neuroimages
Cataldo, R., Agrusti, a, De Nunzio, G., Carlà, a, De Mitri, I., Favetta, M., … Fiorina, E.
PMID: 23157565 ; 2013; Journal Journal of Neuroimaging; vol. 23; no. 3; pp. 473-83; doi:10.1111/j.1552-6569.2012.00713.x
Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.
Haight, T. J., Landau, S. M., Carmichael, O., Schwarz, C., DeCarli, C., & Jagust, W. J.
PMID: 23779022 ; PMCID:3779687 ; 2013; Journal JAMA Neurology; vol. 70; no. 8; pp. 1039-45; doi:10.1001/jamaneurol.2013.1878
Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.
Tosun, D., Joshi, S., & Weiner, M. W.
2013; Journal Annals of Neurology; vol. 74; no. 2; pp. 188-98; doi:10.1002/ana.23921
Functional activity maps based on significance measures and Independent Component Analysis.
Martínez-Murcia, F. J., Górriz, J. M., Ramírez, J., Puntonet, C. G., & Illán, I. a.
2013; Journal Computer Methods and Programs in Biomedicine; vol. 111; no. 1; pp. 255-68; doi:10.1016/j.cmpb.2013.03.015
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease.
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., & Sauer, H.
2013; Journal PloS One; vol. 8; no. 6; pp. e67346; doi:10.1371/journal.pone.0067346
CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer’s disease.
Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.
2013; Journal Acta Neuropathologica; vol. 126; no. 5; pp. 683-697; doi:10.1007/s00401-013-1148-z
Sample size estimates for well-powered cross-sectional cortical thickness studies.
Pardoe, H. R., Abbott, D. F., Jackson, G. D., & Initiative, A. D. N.
2013; Journal Human Brain Mapping; vol. 34; no. 11; pp. 3000-3009; doi:10.1002/hbm.22120
α-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment.
Ane Korff, PhD, Changqin Liu, MD, PhD, Carmen Ginghina, MD, Min Shi, PhD, and Jing Zhang, MD, PhD, for the Alzheimer’s Disease Neuroimaging Initiative
2013; Journal Journal of Alzheimer's Disease; vol. 36; no. 4; pp. 679-688;
Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study.
Leung YY, Toledo J, Nefedov A, et al.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 4; pp. 128-9;